Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis

被引：0

作者：

Daniela Rau

Beate Müller

Susanne Übler

机构：

[1] Nervenfachärztliche Gemeinschaftspraxis Ulm,

[2] Merck Healthcare Germany GmbH (an Affiliate of Merck KGaA,undefined

[3] Darmstadt,undefined

[4] Germany),undefined

来源：

Advances in Therapy | 2023年 / 40卷

关键词：

Cladribine tablets; Multiple sclerosis; Patient-reported outcomes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：5547 / 5556

页数：9

共 77 条

[71]

Rammohan K(undefined)undefined undefined undefined undefined-undefined

[72]

Miravalle AA(undefined)undefined undefined undefined undefined-undefined

[73]

Katz J(undefined)undefined undefined undefined undefined-undefined

[74]

Robertson D(undefined)undefined undefined undefined undefined-undefined

[75]

Hayward B(undefined)undefined undefined undefined undefined-undefined

[76]

Harlow DE(undefined)undefined undefined undefined undefined-undefined

[77]

Lebson LA(undefined)undefined undefined undefined undefined-undefined